Cold & Cough Remedies (Pharmacies) - Cuba

  • Cuba
  • Revenue in the Cold & Cough Remedies market is projected to reach US$24.08m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 3.23%, resulting in a market volume of US$27.35m by 2028.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.15 are generated in 2024.

Key regions: United Kingdom, South Korea, Europe, Japan, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Cuba has been experiencing steady growth in recent years.

Customer preferences:
Cuban consumers have shown a growing preference for over-the-counter cold and cough remedies, which has contributed to the expansion of the market. This can be attributed to several factors. Firstly, there is a growing awareness among consumers about the importance of self-care and managing minor ailments without the need for a doctor's visit. Secondly, the convenience and accessibility of these remedies in pharmacies have made them a popular choice for consumers. Lastly, the affordability of over-the-counter remedies compared to prescription medications has also played a role in driving customer preferences.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Cuba is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of conventional medications and are seeking alternative options. This has led to a rise in the availability and popularity of natural remedies such as herbal teas, honey-based syrups, and essential oils. Pharmacies have responded to this trend by expanding their range of natural products to cater to the changing preferences of consumers. Another trend in the market is the growing emphasis on preventive measures. Cuban consumers are increasingly focused on maintaining good health and preventing illnesses rather than just treating symptoms. This has led to an increased demand for products that boost the immune system and support overall well-being. Pharmacies have capitalized on this trend by offering a wide range of vitamins, supplements, and immune-boosting products to cater to the needs of health-conscious consumers.

Local special circumstances:
Cuba has a well-developed healthcare system that provides free medical services to its citizens. However, due to limited resources, there can be long waiting times for doctor's appointments and limited availability of prescription medications. This has led to an increased reliance on over-the-counter remedies for minor ailments such as colds and coughs. Pharmacies play a crucial role in providing accessible healthcare solutions to the population, making the Cold & Cough Remedies market an essential part of the healthcare landscape in Cuba.

Underlying macroeconomic factors:
The Cold & Cough Remedies (Pharmacies) market in Cuba is influenced by several macroeconomic factors. The country has been experiencing economic reforms in recent years, which have led to an increase in disposable income and improved living standards for many Cubans. This has contributed to the growth of the market as consumers have more purchasing power to spend on healthcare products. Additionally, the government's focus on improving healthcare services and infrastructure has also played a role in driving the demand for over-the-counter remedies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Cuba is growing due to the increasing preference for over-the-counter remedies, the demand for natural and preventive healthcare options, the accessibility of pharmacies, and the macroeconomic factors influencing consumer behavior. As the market continues to evolve, it is expected that pharmacies will play a vital role in meeting the healthcare needs of the population and driving further growth in the Cold & Cough Remedies market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)